The re-emergence of antigen-specific tolerance as a potential therapy for MS
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The re-emergence of antigen-specific tolerance as a potential therapy for MS
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 21, Issue 10, Pages 1223-1238
Publisher
SAGE Publications
Online
2015-04-29
DOI
10.1177/1352458515581441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targets of the humoral autoimmune response in multiple sclerosis
- (2014) Judith Fraussen et al. AUTOIMMUNITY REVIEWS
- Conflicting consequences of immunity to cancer versus autoimmunity to neurons: Insights from paraneoplastic disease
- (2014) Lawrence Steinman EUROPEAN JOURNAL OF IMMUNOLOGY
- From defining antigens to new therapies in multiple sclerosis: Honoring the contributions of Ruth Arnon and Michael Sela
- (2014) Lawrence Steinman et al. JOURNAL OF AUTOIMMUNITY
- The Charcot Lecture | Beating MS: A story of B cells, with twists and turns
- (2014) Stephen L Hauser Multiple Sclerosis Journal
- Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4+ T cells tolerized by peptide immunotherapy
- (2014) Rhoanne C McPherson et al. eLife
- A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
- (2013) Kerrie Vaughan et al. JOURNAL OF NEUROIMMUNOLOGY
- Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients
- (2013) Rebecca C Selter et al. Multiple Sclerosis Journal
- Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes
- (2013) B. O. Roep et al. Science Translational Medicine
- Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis
- (2013) A. Lutterotti et al. Science Translational Medicine
- Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
- (2013) Agata Walczak et al. JAMA Neurology
- Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica
- (2012) Lawrence Steinman et al. ANNALS OF NEUROLOGY
- The discovery of natalizumab, a potent therapeutic for multiple sclerosis
- (2012) Lawrence Steinman JOURNAL OF CELL BIOLOGY
- Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis
- (2012) Francisco J. Quintana et al. JOURNAL OF NEUROIMMUNOLOGY
- Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
- (2012) P. P. Ho et al. Science Translational Medicine
- Anti-Aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica
- (2011) Lukmanee Tradtrantip et al. ANNALS OF NEUROLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS
- (2011) M. S. Freedman et al. NEUROLOGY
- Delivery of myelin peptides through the first line of defense, skin, to counter autoimmunity in multiple sclerosis
- (2010) Lawrence Steinman et al. ANNALS OF NEUROLOGY
- Immune regulation of multiple sclerosis by transdermally applied myelin peptides
- (2010) Maciej Juryńczyk et al. ANNALS OF NEUROLOGY
- Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
- (2008) Hideki Garren et al. ANNALS OF NEUROLOGY
- Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
- (2008) May H. Han et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now